4 not yet recruiting. 4 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Not yet recruiting 4 |
| Phase 1 | 1 | Not yet recruiting 1 |
Follow Impulsive Behavior: new trials by email Literature Review of Impulsive Behavior trials Research Report on Impulsive Behavior
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Lemborexant for Cannabis Use Disorder Lemborexant 10mg, Placebo, Brief Behavioural Intervention - Cannabis Use Disorder | Phase 1 / Phase 2 | Not yet recruiting | University of Calgary | 28 | 2026-11-01 | 2026-09-22 |
| Combination Therapy for Alcohol Use Disorder Placebo, Glucagon-Like Peptide-1 Agonist (GLP-1), Naltrexone (oral tablets) - Alcohol Use Disorder | Phase 2 | Not yet recruiting | Johns Hopkins University | 45 | 2026-11-01 | 2026-10-01 |
| Semaglutide for Treatment of People With Methamphetamine Use Disorder: the SHIFT Study 12 weeks of weekly subcutaneous semaglutide injection - Methamphetamine Use Disorder | Phase 2 | Not yet recruiting | Kirby Institute | 40 | 2026-09-01 | 2026-06-26 |
| A Study of the Safety and Exploratory Efficacy of Oral AFA-281 in Patients with Alcohol Use Disorder AFA-281 - Alcohol Abuse, Alcohol Abuse/addiction | Phase 2 | Not yet recruiting | Afasci Inc | 36 | 2025-10-01 | 2024-11-29 |
Behavior, Addictive (4) · Alcoholism (2) · Anxiety Disorders (1) · Depression (1) · Marijuana Abuse (1) · Sleep Wake Disorders (1) · Substance-Related Disorders (1)
Behavior (4) · Chemically-Induced Disorders (4) · Compulsive Behavior (4) · Mental Disorders (4) · Substance-Related Disorders (3) · Alcohol-Related Disorders (2) · Behavioral Symptoms (1) · Nervous System Diseases (1) · Neurologic Manifestations (1) · Pathological Conditions, Signs and Symptoms (1) · Signs and Symptoms (1)
Naltrexone (1) · lemborexant (1)
Afasci Inc (1) · Johns Hopkins University (1) · Kirby Institute (1) · University of Calgary (1)
United States (2) · Australia (1) · Canada (1)
Andrew S. Huhn, Ph.D. (1) · David N Crockford, MD (1) · Lara Ray, MD (1) · Leah M Mayo, PhD (1) · Stephanie L Borgland, PhD (1)